Trialbee and uMotif Expand Patient Access to Global Trials


Trialbee, a patient matching and enrolment platform, and uMotif, a patient-centric data capture provider, are partnering hoping to improve the patient experience and improve trial accessibility globally. The companies’ integrated platforms simplify trial activities from initial awareness through enrollment and data collection during study conduct and close-out.

Patients are digitally matched to study protocols via Trialbee HIVE. Qualified, study-ready patients are then consented at-site or remotely through the Trialbee platform, which is integrated with uMotif’s application. Once enrolled, patients use the engaging uMotif app to capture large volumes of ePRO, eDiary and symptom data in real-time throughout the duration of a trial. Patients are empowered to manage and collect their data in an application, while sponsors receive an understanding of patient symptoms and behavior.

For more information, click here.

Related Videos
Greg Ball, Founder, ASAP Process Consulting image credit screen shot from video
Janice Chang, CEO, TransCelerate BioPharma @ video screenshot.
Related Content
© 2024 MJH Life Sciences

All rights reserved.